Bank Of Montreal Inovio Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$0.79 - $1.91 $12,197 - $29,490	15,440 New	15,440 $12,000
Q2 2022 Aug 11, 2022	SELL	$1.44 - $3.98 $27,508 - $76,029	-19,103 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.97 - $5.2 $14,618 - $25,594	4,922 Added 34.71%	19,103 $70,000
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $20,938 - $31,302	4,196 Added 42.02%	14,181 $75,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $71,492 - $96,754	9,985 New	9,985 $80,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.02B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.